Testing C1-inhibitor for brain bleed after aneurysm
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a drug called C1-inhibitor (a protein that calms inflammation) given shortly after a bleeding stroke caused by an aneurysm. The goal is to see if it can reduce brain damage and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed brain bleed from a burst aneurysm, seen on a CT scan.
- You are 18 years or older.
- Your condition is rated WFNS grade 1 to 5 (which covers all severity levels from mild to severe).
- You are not in another experimental treatment study.
- You are not expected to die within 24 hours of arriving at the hospital.
- You are not pregnant, and you have no known blood clotting disorder, allergy to blood products or C1-inhibitor, or hereditary complement deficiency.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the drug ticagrelor, which helps prevent blood clots, can reduce the risk of a stroke occurring days after a mild form of bleeding in the brain. It is given as an add-on to the standard treatment for the bleeding aneurysm.
This trial tests a medicine called tirofiban that helps prevent blood clots after a stent is placed to treat a burst brain aneurysm. The goal is to see if adding this medicine improves recovery and reduces the chance of another bleed.
This trial tests if a medicine called cilostazol can reduce the risk of a delayed shortage of blood in the brain after having a bleeding aneurysm treated. It aims to improve recovery by preventing a common complication called delayed cerebral ischemia.
This study tests a blood-thinning medicine called tirofiban to see if it helps reduce delayed brain damage after a type of stroke from a bleeding brain aneurysm. It is for people who have already had their aneurysm fixed with coiling, and the medicine is given soon after.
This trial tests whether placing a small drain in the lower back and giving a clot-dissolving medicine (urokinase) into the fluid around the brain can help people recover from a severe bleeding stroke caused by a brain aneurysm. It is for patients who are treated quickly after the bleed.
This study tests a drug called Cerebrolysin, which may help protect the brain after a bleeding stroke. It is given within 6 hours of the stroke, and researchers will check if it is safe and helps improve recovery.
Hear when a new Subarachnoid Hemorrhage, Aneurysmal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.